使用罗宾汉德指数测量健康不平等:通过元分析进行系统审查
Georgios Farantos1, Athanasios Pitis1, Maria Diamantopoulou1
1Department of Nursing, School of Health Sciences, University of the Peloponnese, 22100 Tripoli, Greece.
Epidemiologia (Basel, Switzerland)
|July 23, 2025
概括
更高的医生密度可能会增加健康不平等,这与预期相反. 这次系统性审查和元分析发现医生再分配和更大的不平等之间存在联系,突出了需要更好的研究方法的需要.
科学领域:
- 卫生经济学 卫生经济学
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- 罗宾汉指数 (RHI) 用于衡量地理健康不平等.
- 关于增加医生密度是否减少RHI测量的不平等的证据是有限的.
- 本研究使用RHI评估了医生分布和健康不平等之间的关联.
研究的目的:
- 系统地审查和分析基于RHI的研究.
- 评估医生密度与健康不平等之间的关系.
- 识别研究缺口并为卫生政策提供信息.
主要方法:
- 按照PRISMA 2020指南进行系统审查和元分析.
- 在PubMed,Scopus和OpenGrey的文献中进行了搜索.
- 提取了关于医生密度和RHI结果的数据;评估了偏差风险.
主要成果:
- 包括17项研究 (720个地区,107亿个人).
- 医生重新分配与不平等的增加密切相关 (r = 0.73,p = 0.0038).
- 分析显示,再分配研究的合并OR为1.24 (95% CI:0.54-2.86).
结论:
- 医生供应的增加与健康不平等的增加有关,尽管确定性有限.
- 在RHI研究中的方法异质性阻碍了可比性.
- 研究和政策指导需要标准化的方法和更广泛的分析模型.
相关概念视频
Bias in Epidemiological Studies
695
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
695
Statistical Methods for Analyzing Epidemiological Data
539
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
539
Relative Risk
348
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
348
Comparing the Survival Analysis of Two or More Groups
291
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
291
Hazard Ratio
255
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
255
The Mantel-Cox Log-Rank Test
570
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
570


